Showing results (1161-1170 of 1,193) with videos related to

Sort By:
Pageof 120
Blood Cancer Discovery|January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Genome Research|March 24, 2018
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutationsMaitri Y Shah, Manuela Ferracin, Valentina Pileczki, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2026
Establishment of epidemiological cutoff values for clinically relevant Sporothrix species using CLSI-broth microdilutionAmanda R Dos Santos, Alexandro Bonifaz, Amanda Bombassaro, et al.
Blood|September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemiaEric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
The New England Journal of Medicine|January 9, 2020
Luspatercept in Patients with Lower-Risk Myelodysplastic SyndromesPierre Fenaux, Uwe Platzbecker, Ghulam J Mufti, et al.
The Lancet. Infectious Diseases|August 22, 2021
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASMSharon C-A Chen, John Perfect, Arnaldo L Colombo, et al.
International Journal of Molecular Sciences|January 21, 2023
Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in MenPablo García-González, Itziar de Rojas, Sonia Moreno-Grau, et al.
Nature Cancer|September 19, 2024
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analysesCourtney D DiNardo, Divij Verma, Natalia Baran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2025
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Elena Riva, Luca Lanino, et al.
Pageof 120